As the most reliable and balanced news aggregation service on the internet, DML News App offers the following information published by NYPost.com:
The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.
The treatment is aimed at those with mild cases of COVID-19, and not for those hospitalized as a result of the virus, the FDA said.
The article goes on to state the following:
The treatment works by mimicking the body’s own immune system to prevent the infected from become severely ill.
To get more information about this article, please visit NYPost.com.